<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McIntire KM</submitter><funding>Ministry of Education</funding><funding>NCATS NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>Collaborative Influenza Vaccine Innovation Centers</funding><funding>National Institutes of Health</funding><funding>National Research Foundation of Korea</funding><funding>Centers of Excellence for Influenza Research and Response</funding><funding>NIH HHS</funding><funding>Centers of Excellence for Influenza Research and Surveillance</funding><pagination>e20240668</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11211068</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>221(8)</volume><pubmed_abstract>Germinal centers (GC) are microanatomical lymphoid structures where affinity-matured memory B cells and long-lived bone marrow plasma cells are primarily generated. It is unclear how the maturation of B cells within the GC impacts the breadth and durability of B cell responses to influenza vaccination in humans. We used fine needle aspiration of draining lymph nodes to longitudinally track antigen-specific GC B cell responses to seasonal influenza vaccination. Antigen-specific GC B cells persisted for at least 13 wk after vaccination in two out of seven individuals. Monoclonal antibodies (mAbs) derived from persisting GC B cell clones exhibit enhanced binding affinity and breadth to influenza hemagglutinin (HA) antigens compared with related GC clonotypes isolated earlier in the response. </pubmed_abstract><journal>The Journal of experimental medicine</journal><pubmed_title>Maturation of germinal center B cells after influenza virus vaccination in humans.</pubmed_title><pmcid>PMC11211068</pmcid><funding_grant_id>U19AI089992</funding_grant_id><funding_grant_id>HHSN272201400008C</funding_grant_id><funding_grant_id>75N93019C00051</funding_grant_id><funding_grant_id>U01 AI144616</funding_grant_id><funding_grant_id>5T32AI007163-44</funding_grant_id><funding_grant_id>R01AI168178-01</funding_grant_id><funding_grant_id>U01 AI141990</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>2021R1A6A3A03041509</funding_grant_id><funding_grant_id>U01 AI150747</funding_grant_id><funding_grant_id>5U01AI144616-02</funding_grant_id><funding_grant_id>R01AI104739</funding_grant_id><funding_grant_id>R01 AI104739</funding_grant_id><funding_grant_id>75N93021C00014</funding_grant_id><funding_grant_id>U01AI141990</funding_grant_id><funding_grant_id>T32 AI007163</funding_grant_id><funding_grant_id>U19 AI089992</funding_grant_id><funding_grant_id>1U01AI150747</funding_grant_id><funding_grant_id>R01 AI168178</funding_grant_id><pubmed_authors>Turner JS</pubmed_authors><pubmed_authors>Zhou JQ</pubmed_authors><pubmed_authors>Yellin T</pubmed_authors><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Suessen T</pubmed_authors><pubmed_authors>Middleton WD</pubmed_authors><pubmed_authors>Krammer F</pubmed_authors><pubmed_authors>McIntire KM</pubmed_authors><pubmed_authors>Kleinstein SH</pubmed_authors><pubmed_authors>McMahon M</pubmed_authors><pubmed_authors>Malladi SK</pubmed_authors><pubmed_authors>Moore NE</pubmed_authors><pubmed_authors>Ward AB</pubmed_authors><pubmed_authors>Schmitz AJ</pubmed_authors><pubmed_authors>Ellebedy AH</pubmed_authors><pubmed_authors>Lin TH</pubmed_authors><pubmed_authors>Wilson IA</pubmed_authors><pubmed_authors>Kim W</pubmed_authors><pubmed_authors>Mohammed BM</pubmed_authors><pubmed_authors>Carreno JM</pubmed_authors><pubmed_authors>Presti RM</pubmed_authors><pubmed_authors>Han J</pubmed_authors><pubmed_authors>Teefey SA</pubmed_authors><pubmed_authors>Meng H</pubmed_authors><pubmed_authors>Hoehn KB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Maturation of germinal center B cells after influenza virus vaccination in humans.</name><description>Germinal centers (GC) are microanatomical lymphoid structures where affinity-matured memory B cells and long-lived bone marrow plasma cells are primarily generated. It is unclear how the maturation of B cells within the GC impacts the breadth and durability of B cell responses to influenza vaccination in humans. We used fine needle aspiration of draining lymph nodes to longitudinally track antigen-specific GC B cell responses to seasonal influenza vaccination. Antigen-specific GC B cells persisted for at least 13 wk after vaccination in two out of seven individuals. Monoclonal antibodies (mAbs) derived from persisting GC B cell clones exhibit enhanced binding affinity and breadth to influenza hemagglutinin (HA) antigens compared with related GC clonotypes isolated earlier in the response. </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-06-01T18:09:36.949Z</modification><creation>2025-04-03T23:44:23.204Z</creation></dates><accession>S-EPMC11211068</accession><cross_references><pubmed>38935072</pubmed><doi>10.1084/jem.20240668</doi></cross_references></HashMap>